|
ZA836080B
(en)
*
|
1982-08-23 |
1984-04-25 |
Scripps Clinic Res |
Broad spectrum influenza antisera
|
|
US5182192A
(en)
|
1987-03-27 |
1993-01-26 |
The Wistar Institute |
Monoclonal antibodies against glycolipid antigens, methods of producing these antibodies, and use therefor
|
|
US5854037A
(en)
|
1989-08-28 |
1998-12-29 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
US6001634A
(en)
|
1989-08-28 |
1999-12-14 |
Palese; Peter |
Recombinant negative strand RNA viruses
|
|
US6887699B1
(en)
|
1990-05-22 |
2005-05-03 |
Medimmune Vaccines, Inc. |
Recombinant negative strand RNA virus expression systems and vaccines
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
FR2664905B1
(fr)
|
1990-07-18 |
1994-08-12 |
Agronomique Inst Nat Rech |
Baculovirus modifie, son procede d'obtention, et vecteurs d'expression obtenus a partir dudit baculovirus.
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
WO1992003918A1
(en)
|
1990-08-29 |
1992-03-19 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
DK1024191T3
(da)
|
1991-12-02 |
2008-12-08 |
Medical Res Council |
Fremstilling af autoantistoffer fremvist på fag-overflader ud fra antistofsegmentbiblioteker
|
|
US6337070B1
(en)
|
1993-04-29 |
2002-01-08 |
Takara Shuzo Co., Ltd. |
Polypeptides for use in generating anti-human influenza virus antibodies
|
|
US5589174A
(en)
|
1992-09-17 |
1996-12-31 |
Takara Shuzo Co., Ltd. |
Anti-human influenza virus antibody
|
|
JP3037554B2
(ja)
|
1993-04-20 |
2000-04-24 |
寳酒造株式会社 |
免疫原性人工ポリペプチド
|
|
EP0621339B1
(en)
|
1992-09-17 |
2001-10-24 |
Takara Shuzo Co. Ltd. |
Immunogenic human influenza A virus haemagglutinin polypeptides
|
|
GB9221654D0
(en)
|
1992-10-15 |
1992-11-25 |
Scotgen Ltd |
Recombinant human anti-cytomegalovirus antibodies
|
|
WO1994016109A1
(en)
*
|
1993-01-15 |
1994-07-21 |
Whitehead Institute For Biomedical Research |
Membrane fusion events and means for altering same
|
|
WO1994017826A1
(en)
|
1993-02-01 |
1994-08-18 |
Smithkline Beecham Corporation |
Vaccinal polypeptides
|
|
US5573916A
(en)
*
|
1994-05-19 |
1996-11-12 |
Coretech, Inc. |
Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier
|
|
US5622701A
(en)
|
1994-06-14 |
1997-04-22 |
Protein Design Labs, Inc. |
Cross-reacting monoclonal antibodies specific for E- and P-selectin
|
|
AU5632296A
(en)
|
1995-04-27 |
1996-11-18 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
CA2219486A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
|
JP4215172B2
(ja)
|
1996-12-03 |
2009-01-28 |
アムジェン フレモント インク． |
複数のＶ▲下Ｈ▼およびＶ▲下κ▼領域を含むヒトＩｇ遺伝子座を有するトランスジェニック哺乳動物、ならびにそれから産生される抗体
|
|
US6165476A
(en)
|
1997-07-10 |
2000-12-26 |
Beth Israel Deaconess Medical Center |
Fusion proteins with an immunoglobulin hinge region linker
|
|
PL357523A1
(en)
|
1999-04-29 |
2004-07-26 |
Syngenta Ltd. |
Herbicide resistant plants
|
|
CO5280082A1
(es)
*
|
1999-09-24 |
2003-05-30 |
Smithkline Beecham Corp |
Nueva vacuna
|
|
US7521220B2
(en)
|
1999-11-26 |
2009-04-21 |
Crucell Holland B.V. |
Production of vaccines
|
|
AU5921101A
(en)
*
|
2000-04-28 |
2001-11-12 |
St Jude Childrens Res Hospital |
Dna transfection system for the generation of infectious influenza virus
|
|
US6632620B1
(en)
|
2000-06-22 |
2003-10-14 |
Andrew N. Makarovskiy |
Compositions for identification and isolation of stem cells
|
|
EP3009507B1
(en)
|
2002-02-13 |
2020-06-24 |
Wisconsin Alumini Research Foundation |
Signal for packaging of influenza virus vectors
|
|
US20040091503A1
(en)
|
2002-08-20 |
2004-05-13 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
|
AU2004207838B2
(en)
|
2003-01-29 |
2010-04-22 |
The Research Foundation Of State University Of New York |
Tolerance-induced targeted antibody production
|
|
DE602004020189D1
(de)
*
|
2003-01-30 |
2009-05-07 |
Novartis Vaccines & Diagnostic |
Adjuvante influenza-vakzine
|
|
JP4368594B2
(ja)
*
|
2003-02-24 |
2009-11-18 |
株式会社インシリコサイエンス |
タンパク質構造予測装置、タンパク質構造予測方法、プログラム、および、記録媒体
|
|
NZ543348A
(en)
|
2003-05-05 |
2008-08-29 |
Thompson Boyce Plant Res |
Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
|
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
DK2261380T3
(da)
*
|
2003-11-04 |
2013-10-07 |
Univ Tulane |
Fremgangsmåde til hindring af virus:celle-fusion ved hæmning af funktionen af fusionsinitieringsregionen i RNA vira med klasse I membranfusogene indhyldningsproteiner
|
|
CA2822895A1
(en)
*
|
2004-05-25 |
2005-12-08 |
Medimmune, Llc |
Influenza hemagglutinin and neuraminidase variants
|
|
US7566454B2
(en)
*
|
2005-02-24 |
2009-07-28 |
University Of Massachusetts |
Influenza nucleic acids, polypeptides, and uses thereof
|
|
WO2006130855A2
(en)
|
2005-06-01 |
2006-12-07 |
California Institute Of Technology |
Method of targeted gene delivery using viral vectors
|
|
JP4758148B2
(ja)
|
2005-06-14 |
2011-08-24 |
泰三 宇田 |
インフルエンザウイルスのヘマグルチニンに対する抗体酵素
|
|
PL1951299T3
(pl)
*
|
2005-11-04 |
2012-07-31 |
Novartis Ag |
Szczepionki przeciw grypie zawierające kombinacje adiuwantów cząsteczkowych i czynników wzmacniających immunogenność
|
|
CL2006003348A1
(es)
|
2005-12-02 |
2008-02-22 |
Mount Sinai Medical Ct Of New York University |
Virus de influenza aviar quimericos; metodo de produccion de una composicion inmunogena; y metodo para inducir una respuesta inmunitaria a dos agentes infecciosos en un ave o humano.
|
|
US7914797B2
(en)
*
|
2005-12-06 |
2011-03-29 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Influenza vaccine
|
|
US10183986B2
(en)
|
2005-12-15 |
2019-01-22 |
Industrial Technology Research Institute |
Trimeric collagen scaffold antibodies
|
|
EP3011969A1
(en)
|
2006-03-07 |
2016-04-27 |
Vaxinnate Corporation |
Compositions that include hemagglutinin, methods of making and methods of use thereof
|
|
JP2009537147A
(ja)
|
2006-05-15 |
2009-10-29 |
シー レーン バイオテクノロジーズ， エルエルシー |
インフルエンザウイルスに対する中和抗体
|
|
US8148085B2
(en)
|
2006-05-15 |
2012-04-03 |
Sea Lane Biotechnologies, Llc |
Donor specific antibody libraries
|
|
WO2008054540A2
(en)
*
|
2006-05-18 |
2008-05-08 |
Pharmexa Inc. |
Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
|
|
US20100143406A1
(en)
|
2006-06-30 |
2010-06-10 |
Gale Smith |
Methods of enhancing protein incorporation into virus like particles
|
|
AU2007275010B2
(en)
|
2006-07-21 |
2013-06-20 |
California Institute Of Technology |
Targeted gene delivery for dendritic cell vaccination
|
|
AU2007293662B2
(en)
|
2006-09-07 |
2012-10-04 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus H5N1 and uses thereof
|
|
BRPI0716536A2
(pt)
|
2006-09-11 |
2013-09-24 |
Novartis Ag |
produÇço de vacinas de vÍrus influenza, sem a utilizaÇço de ovos
|
|
CN103254308B
(zh)
*
|
2007-06-15 |
2015-01-21 |
厦门大学 |
H5亚型禽流感病毒血凝素蛋白的单克隆抗体或其结合活性片段及其用途
|
|
EP2014279A1
(en)
*
|
2007-06-22 |
2009-01-14 |
Pevion Biotech AG |
Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof
|
|
CA2615372A1
(en)
|
2007-07-13 |
2009-01-13 |
Marc-Andre D'aoust |
Influenza virus-like particles (vlps) comprising hemagglutinin
|
|
US20090092635A1
(en)
|
2007-08-17 |
2009-04-09 |
Wyeth |
Heterologous prime-boost immunization regimen
|
|
US9421254B2
(en)
*
|
2007-09-24 |
2016-08-23 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Immunostimulatory combinations of TLR ligands and methods of use
|
|
FR2921387B1
(fr)
|
2007-09-26 |
2012-04-20 |
Sanofi Pasteur |
Procede de production du virus de la grippe
|
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
|
KR20100120157A
(ko)
|
2007-11-27 |
2010-11-12 |
메디카고 인코포레이티드 |
헤마글루티닌을 발현하는 트랜스제닉 식물에서 생산된 재조합 인플루엔자 바이러스-유사 입자(ＶＬＰｓ)
|
|
CN101970483A
(zh)
|
2007-12-06 |
2011-02-09 |
达纳-法伯癌症研究公司 |
抗流感病毒抗体及其使用方法
|
|
ITTO20080204A1
(it)
|
2008-03-17 |
2009-09-18 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
|
|
JP2011516423A
(ja)
|
2008-03-28 |
2011-05-26 |
シー レーン バイオテクノロジーズ， エルエルシー |
ウイルス抗原に対する中和分子
|
|
GB0905570D0
(en)
|
2009-03-31 |
2009-05-13 |
Novartis Ag |
Combined vaccines
|
|
ES2524553T3
(es)
*
|
2008-06-17 |
2014-12-10 |
Apogenix Gmbh |
Receptores multiméricos de TNF
|
|
ES2445798T3
(es)
|
2008-06-25 |
2014-03-05 |
Inserm - Institut National De La Santé Et De La Recherche Médicale |
Novedosos compuestos inmunoadyuvantes basados en flagelina y uso de los mismos
|
|
US8771703B2
(en)
|
2008-07-08 |
2014-07-08 |
Medicago Inc. |
Soluble recombinant influenza antigens
|
|
US9051359B2
(en)
*
|
2009-03-30 |
2015-06-09 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus vaccines and uses thereof
|
|
MY183517A
(en)
|
2009-05-11 |
2021-02-24 |
Janssen Vaccines & Prevention Bv |
Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
|
|
CA2800182A1
(en)
*
|
2009-05-26 |
2010-12-02 |
Mount Sinai School Of Medicine |
Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
|
|
BRPI1015053A2
(pt)
|
2009-06-24 |
2019-07-09 |
Medicago Inc |
partículas similares a vírus da influenza quiméricas compreendendo hemaglutinina
|
|
JP5845180B2
(ja)
*
|
2009-07-30 |
2016-01-20 |
モウント シナイ スクール オフ メディシネ |
インフルエンザウイルス及びそれらの使用
|
|
JP5463107B2
(ja)
|
2009-09-14 |
2014-04-09 |
独立行政法人国立国際医療研究センター |
新型インフルエンザを特異的に鑑別するモノクローナル抗体とそれを利用した免疫検出試薬
|
|
JP2013060367A
(ja)
|
2010-01-15 |
2013-04-04 |
Osaka Univ |
抗インフルエンザ抗体及びインフルエンザ検出用デバイス
|
|
US8298820B2
(en)
*
|
2010-01-26 |
2012-10-30 |
The Trustees Of The University Of Pennsylvania |
Influenza nucleic acid molecules and vaccines made therefrom
|
|
KR20120132506A
(ko)
|
2010-02-18 |
2012-12-05 |
마운트 시나이 스쿨 오브 메디슨 |
인플루엔자 바이러스 질환의 예방 및 치료에 사용되는 백신
|
|
CA2849668A1
(en)
|
2010-03-08 |
2011-09-15 |
Celltrion, Inc. |
Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses
|
|
WO2011123495A1
(en)
|
2010-03-30 |
2011-10-06 |
Mount Sinai School Of Medicine |
Influenza virus vaccines and uses thereof
|
|
CA2806250C
(en)
|
2010-07-22 |
2020-09-22 |
John W. Schrader |
Cross-protective pathogen protection, methods and compositions thereof
|
|
CN108164602A
(zh)
|
2011-09-20 |
2018-06-15 |
西奈山医学院 |
流感病毒疫苗及其应用
|
|
BR112014012681A8
(pt)
|
2011-11-28 |
2017-06-20 |
Crucell Holland Bv |
polipeptídeo, métido para proporcionar um polipeptídeo, ácido nucleico, e, composição imunogênica
|
|
CA2894506C
(en)
|
2012-12-11 |
2021-08-10 |
Vib Vzw |
Anti-influenza antibody
|
|
CN105263516A
(zh)
|
2012-12-18 |
2016-01-20 |
西奈山伊坎医学院 |
流感病毒疫苗及其用途
|